ASH 2010 Conference Coverage

Scent-trained dog detects thyroid cancer in human urine samples

A canine trained to identify cancer in urine samples by scent was able to differentiate thyroid cancer from benign status nearly 90 percent of the time.

Report shows U.S. cancer deaths on the decline

According to a new report published in the Journal of the National Cancer Institute, there has been a continuing decline in cancer deaths in the United States between 2002 and 2011.

Leafy green vegetables may slow mental deterioration

Researchers have found that a single serving of leafy green vegetables each day may slow dementia.

Effective management of dietary cholesterol may prevent metastasis in patients with prostate cancer

New findings from researchers in Australia indicate dietary measures may prevent metastasis of prostate cancer.

Risk of breast cancer in transgender persons studied in veterans

A study of breast cancer in transgender veterans has identified 10 new cases, increases the number of recorded cases in transgender individuals.

Chromosomal rearrangement is key to progress against aggressive infant leukemia

Current research indicates that a rare but aggressive subtype of pediatric acute lymphoblastic leukemia (ALL) has surprisingly few mutations beyond the chromosomal rearrangement that affects the MLL gene.

Risk of thyroid cancer increases after a breast cancer diagnosis

Breast cancer survivors have a higher risk of developing thyroid cancer, especially within 5 years of their breast cancer diagnosis, according to a national database analysis.

Vaccine may delay recurrence for advanced ovarian cancers

Researchers have found that a vaccine delayed cancer recurrence in women with stage III or IV ovarian cancers.

High fish intake may improve survival after breast cancer

Long-chain ω-3 polyunsaturated fatty acid intake from fish and other dietary sources may provide a potential strategy to improve survival after breast cancer, a new study published online early in the journal Cancer has found.

Adding bevacizumab to standard chemotherapy improves overall survival for women with ovarian cancer

Preliminary findings from the Gynecologic Oncology Group's (GOG) GOG 213 study show an improvement in overall survival for women with ovarian cancer when bevacizumab is added to standard chemotherapy.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs